OptiNose Components definition

OptiNose Components shall have the meaning set forth in Section 2.1(e).
Sample 1Sample 2Sample 3
OptiNose Components means the consigned inventory that has the meaning set forth in Section 2.02(a).
Sample 1
OptiNose Components means the consigned inventory that has the meaning set forth in Section 2.02(a). “OptiNose Equipment” means equipment (i) that can be used only for production of DSA’s under this Agreement or (ii) that OptiNose desires to have dedicated solely to the production of DSA’s under this Agreement. “OptiNose Indemnitee” shall have the meeting set forth in Section 12.02. “OptiNose Information” means any documents, data, know-how, trade secrets, methodologies, software and other information (Confidential Information or otherwise) provided to VTM by or on behalf of OptiNose or developed by VTM on behalf of OptiNose, including without limitation computer programs, reports and specifications. “OptiNose Supply Relationship Manager” shall have the meaning set forth in Section 7.01(a) 4 [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. “Patent Defect” means any instance where any DSA fails to conform to the Specifications, Quality Agreement or applicable Laws, where such failure is or was discoverable upon reasonable physical inspection upon receipt by OptiNose or its designee. “Person” means an individual, corporation, partnership, joint venture, limited liability company, governmental authority, unincorporated organization, trust, association or other entity. “Production Materials” shall mean materials that are consumed in the production processes to manufacture DSAs including without limitation, [***]; Production Materials do not include any such production materials that have been specified by OptiNose. “Purchase Order” shall have the meaning set forth in Section 2.09(a). “Quality Agreement” means that Quality Agreement between OptiNose and VTM to be entered between the parties related to production of the DSAs. “Quantitative Defect” means any instance in which VTM has delivered a quantity that is [***] less than, or [***] greater than, the quantity stated in any invoice or xxxx of lading. “Receiving Party” means a party that receives or acquires Confidential Information directly or indirectly under this Agreement. “Special Inventory” shall mean any mutually agreed Inventory acquired by VTM to support flexibility, demand requirements, safety stock or pricing discounts. “Specifications” shall mean the procedures, standards, quality control and other data and requirements for each DSA, which shall include, without l...
Sample 1

Examples of OptiNose Components in a sentence

  • Section 6.05 Upon VTM’s receipt of OptiNose Components, VTM shall promptly inspect such OptiNose Components in accordance with the applicable inspection criteria provided by OptiNose and ensure that such OptiNose Components provided by each such supplier meets the applicable specifications for such OptiNose Components.

  • CPL shall do such inspection within [***] ([***]) business days of its receipt of such OptiNose Components, provided it shall have [***] ([***]) days for its inspection of the API.

  • If VTM fails to deliver the DSAs in the quantities ordered in any Purchase Order within [***] of the date specified in such Purchase Order, then in addition to, and without waiver or limitation of any of its other rights hereunder, at law or in equity, in all instances VTM shall use [***] to timely deliver DSAs even if there were prior delays in the OptiNose Components due to [***].

  • Notwithstanding the foregoing, VTM shall at OptiNose’s request warehouse [***] any and all OptiNose Components that VTM previously manufactured for OptiNose pursuant to the Molded Parts Agreement.

  • Notwithstanding anything contained in this Agreement to the contrary and other than as set forth in Section 3.09(d), in no case shall VTM maintain more than a [***] supply of Inventory (other than OptiNose Components) based on the then [***] rolling forecast without OptiNose’s prior written consent.

  • The parties acknowledge that the OptiNose Components are the substantial majority of the inputs to the LDSAs by value and that the OptiNose Components will be the property of OptiNose at all times that such OptiNose Components are in Ximedica’s possession.

  • CPL shall provide monthly inventory reports of OptiNose Components and all other Raw Material inventoried by CPL solely for the manufacture of Product.

  • Ximedica agrees to enter a bailment agreement with OptiNose in the form reasonably acceptable to both parties for the OptiNose Equipment, the OptiNose Components, partially completed LDSAs containing OptiNose Components, and completed LDSAs.

  • VTM agrees to enter a bailment agreement with OptiNose in the form reasonably acceptable to both parties for the OptiNose Equipment, and the OptiNose Components.

  • VTM will reference the latest available Forecasts when ordering Inventory (excluding the OptiNose Components which shall be ordered by OptiNose) necessary or appropriate to fulfill the forecasted DSA requirements, taking into account necessary lead times, volume-based pricing, the applicable Inventory’ expiration periods, the Binding Period, and any Purchase Orders for DSAs outside the Binding Period.

Related to OptiNose Components

  • Third Party Components means software and interfaces, licensed by RIM from a third party for incorporation into a RIM software product, or for incorporation into firmware in the case of RIM hardware products, and distributed as an integral part of that RIM product under a RIM brand, but shall not include Third Party Software.

  • Bearing components means the bearing element, retainer, inner race, or outer race.

  • Finished Product means a cannabis product in its final form to be sold at a retail premises.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Combination Product means a product that includes a device for delivery or at least one active ingredient other than a Licensed Product.

  • Manufacturing Site means a location where a manufacturing

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Aerosol coating product means a pressurized coating product containing pigments or resins that dispenses product ingredients by means of a propellant, and is packaged in a disposable can for hand-held application, or for use in specialized equipment for ground traffic/marking applications.

  • Licensed Compound means (a) 3,4-Diaminopyridine, the chemical structure of which is set forth on Exhibit B-2; and (b) any derivatives, isomers, metabolites, prodrugs, acid forms, base forms, salt forms, or modified versions of such compound in (a).

  • Replacement Product means electric generating capacity, capacity-related benefits, environmental attributes, Energy or other electric products from a generation resource other than the Facility that are provided or delivered to replace or substitute for Contract Capacity or Storage Capacity (or any Capacity-Related Benefit, Environmental Attribute, Other Electric Product, Contract Energy, or Storage Energy associated therewith), in each case, in whole or in part, pursuant to Section 4.6.

  • Assay means a laboratory analysis of Crude Petroleum to include the following: A.P.I. Gravity, Reid vapor pressure, composition, pour point, water and sediment content, sulfur content, viscosity, distillation, hydrogen sulfide, flash/boiling point and other characteristics as may be required by Carrier.

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Active Ingredient means any com- ponent that is intended to furnish pharmacological activity or other di- rect effect in the diagnosis, cure, miti- gation, treatment, or prevention of dis- ease, or to affect the structure or any function of the body of humans. The term includes those components that may undergo chemical change in the manufacture of the drug product and be present in the drug product in a modified form intended to furnish the specified activity or effect.

  • Covered Products means Your Applications, Libraries, Passes, Safari Extensions, Safari Push Notifications, and/or FPS implementations developed under this Agreement.

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • Diagnostic Product means In Vitro Diagnostics, In Vivo Diagnostic Agents and any other aptamer product used for Diagnosis. For purposes of clarity, the term Diagnostic Product shall not include a product used for the delay of onset or progression of, or treatment or prevention of, an Indication.